Spinosin, a C-Glucosylflavone, from Zizyphus jujuba var. spinosa Ameliorates Aβ1-42 Oligomer-Induced Memory Impairment in Mice

초록

Alzheimer's disease (AD) is a neurodegenerative disorder associated with progressive memory loss and neuronal cell death. Although numerous previous studies have been focused on disease progression or reverse pathological symptoms, therapeutic strategies for AD are limited. Alternatively, the identification of traditional herbal medicines or their active compounds has received much attention. The aims of the present study were to characterize the ameliorating effects of spinosin, a C-glucosylflavone isolated from Zizyphus jujube var. spinosa, on memory impairment or the pathological changes induced through amyloid-beta(1-42) oligomer (A beta O) in mice. Memory impairment was induced by intracerebroventricular injection of A beta O (50 mu M) and spinosin (5, 10, and 20 mg/kg) was administered for 7 days. In the behavioral task's, the subchronic administration of spinosin (20 mg/kg, p.o.) significantly ameliorated A beta O-induced cognitive impairment in the passive avoidance task or the Y-maze task. To identify the effects of spinosin on the pathological changes induced through A beta O, immunohistochemistry and Western blot analyses were performed. Spinosin treatment also reduced the number of activated nnicroglia and astrocytes observed after A beta O injection. In addition, spinosin rescued the A beta O-induced decrease in choline acetyltransferase expression levels. These results suggest that spinosin ameliorated memory impairment induced through A beta O, and these effects were regulated, in part, through neuroprotective activity via the anti-inflammatory effects of spinosin. Therefore, spinosin might be a useful agent against the amyloid beta protein-induced cognitive dysfunction observed in AD patients.

키워드